Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
688302 Hinova Pharmaceuticals Inc.
- 45.69
- -2.31-4.81%
Market Closed May 12 15:00 CST
4.52BMarket Cap-24.54P/E (TTM)
46.95High44.08Low38.36KlotVolume45.98Open48.00Pre Close175.29MTurnover4.71%Turnover RatioLossP/E (Static)99.02MShares48.8852wk High3.89P/B3.72BFloat Cap22.6052wk Low57.60Limit Up81.52MShs Float78.77Historical High38.40Limit Down5.98%Amplitude22.60Historical Low--Dividend TTM45.70Avg Price22.25KlotAsk--Div YieldTTM100Lot Size13.52KlotBid
Hinova Pharmaceuticals Inc. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | --5K | --414.35K | --364.24K | --310K | ---- | ---- | ---- | ---- | ---- | --1.65M |
| Refunds of taxes and levies | ---- | ---- | -95.89%412.48K | -98.72%128.46K | --51.92K | 43.70%19.84M | 66.50%10.04M | 66.50%10.04M | ---- | 123.87%13.81M |
| Cash received relating to other operating activities | 81.72%4.89M | 15.85%20.61M | 45.01%16.12M | 98.26%14.28M | -10.87%2.69M | -21.85%17.79M | 22.53%11.12M | 9.08%7.2M | -39.24%3.02M | -4.13%22.76M |
| Cash inflows from operating activities | 78.46%4.9M | -44.14%21.02M | -20.14%16.9M | -14.66%14.72M | -9.15%2.75M | -1.54%37.63M | 40.09%21.16M | 36.50%17.25M | -39.24%3.02M | 27.79%38.22M |
| Goods services cash paid | --547.83K | --292.19K | --270K | --270K | ---- | ---- | ---- | ---- | ---- | --866.11K |
| Staff behalf paid | -18.69%17.13M | 4.17%70.14M | 4.55%54.31M | 15.00%36.78M | 11.02%21.07M | 25.46%67.34M | 35.88%51.94M | 17.42%31.98M | 9.67%18.98M | 46.97%53.67M |
| All taxes paid | 35.24%74.3K | -1.96%438.45K | -23.11%294.52K | -26.83%231.93K | -35.63%54.94K | 28.24%447.21K | 162.73%383.04K | 117.66%317K | 171.96%85.35K | 242.74%348.73K |
| Cash paid relating to other operating activities | -47.03%22.4M | -39.10%137.23M | -39.72%102.01M | -32.73%76.57M | -11.86%42.29M | -24.44%225.35M | 0.69%169.23M | -15.06%113.82M | -20.16%47.98M | 34.89%298.26M |
| Cash outflows from operating activities | -36.68%40.15M | -29.01%208.1M | -29.19%156.88M | -22.08%113.85M | -5.41%63.41M | -16.99%293.14M | 7.32%221.55M | -9.46%146.12M | -13.42%67.04M | 37.02%353.14M |
| Net cash flows from operating activities | 41.89%-35.25M | 26.78%-187.08M | 30.15%-139.98M | 23.08%-99.14M | 5.24%-60.67M | 18.87%-255.51M | -4.73%-200.39M | 13.36%-128.88M | 11.65%-64.02M | -38.23%-314.92M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -54.54%350.05M | -21.29%3.95B | -29.44%2.78B | -31.73%1.87B | -13.97%770M | -0.04%5.01B | 47.30%3.93B | 32.94%2.73B | 16.23%895M | 29.90%5.01B |
| Cash received from returns on investments | -75.59%938.22K | -43.45%14.04M | -50.56%9.94M | -48.61%7.41M | -21.66%3.84M | -15.30%24.83M | 51.91%20.11M | 48.04%14.41M | 20.05%4.91M | 26.36%29.31M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -90.08%2.18K | -89.28%100 | -72.22%100 | ---- | 21,833.00%21.93K | --933 | --360 | --360 | --100 |
| Cash received relating to other investing activities | --22.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -51.69%373.87M | -21.40%3.96B | -29.55%2.78B | -31.82%1.87B | -14.01%773.84M | -0.13%5.04B | 47.33%3.95B | 33.02%2.75B | 16.25%899.91M | 29.88%5.04B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -0.83%26.66M | -9.71%89.55M | 42.10%109.93M | 39.97%78.75M | 28.47%26.89M | 43.30%99.18M | 118.92%77.36M | 157.40%56.27M | 32.35%20.93M | 250.04%69.21M |
| Cash paid to acquire investments | -40.74%720.05M | -23.27%3.87B | -28.04%2.91B | -30.11%2.02B | -0.65%1.22B | -6.45%5.04B | -1.15%4.04B | 19.88%2.88B | 58.83%1.22B | 39.48%5.38B |
| Cash paid relating to other investing activities | --6.66M | --34.74M | ---- | ---- | ---- | ---- | --100M | --100M | ---- | ---- |
| Cash outflows from investing activities | -39.34%753.37M | -22.33%3.99B | -28.46%3.01B | -31.11%2.09B | -0.16%1.24B | -5.81%5.14B | 2.31%4.21B | 25.23%3.04B | 58.30%1.24B | 40.55%5.45B |
| Net cash flows from investing activities | 18.92%-379.49M | 69.55%-30.25M | 11.97%-229.99M | 24.42%-221.35M | -36.05%-468.04M | 75.77%-99.33M | 81.81%-261.25M | 19.13%-292.85M | -2,834.13%-344.02M | -12,068.62%-409.9M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.01B |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | -98.33%500K | --500K | ---- | ---- | --30M |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | -99.95%500K | -99.95%500K | ---- | ---- | --1.04B |
| Borrowing repayment | ---- | ---- | ---- | ---- | ---- | --30.5M | --500K | ---- | ---- | ---- |
| Dividend interest payment | ---- | ---- | -69.30%386.14K | -67.37%267.49K | -61.13%145.71K | -76.97%904K | -57.73%1.26M | -62.28%819.81K | 405.37%374.84K | 53.42%3.92M |
| Cash payments relating to other financing activities | 85.04%1.22M | -7.61%4.06M | -6.38%2.82M | -19.43%1.49M | -44.44%659.4K | -76.62%4.39M | -82.78%3.01M | -88.88%1.85M | -77.16%1.19M | 246.53%18.78M |
| Cash outflows from financing activities | 51.55%1.22M | -88.67%4.06M | -32.77%3.21M | -34.17%1.75M | -48.44%805.11K | 57.65%35.79M | -76.70%4.77M | -85.80%2.67M | -70.37%1.56M | 167.82%22.71M |
| Net cash flows from financing activities | -51.55%-1.22M | 88.51%-4.06M | 24.90%-3.21M | 34.17%-1.75M | 48.44%-805.11K | -103.47%-35.29M | -100.43%-4.27M | -100.27%-2.67M | 70.37%-1.56M | 12,101.05%1.02B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -216.52%-135.44K | -18.35%1.43M | -137.89%-1.08M | -83.97%558.18K | 109.58%116.24K | -77.59%1.75M | -70.96%2.84M | -24.78%3.48M | -231.32%-1.21M | 491.31%7.8M |
| Net increase in cash and cash equivalents | 21.40%-416.11M | 43.36%-219.96M | 19.18%-374.25M | 23.58%-321.68M | -28.87%-529.4M | -229.30%-388.38M | 26.26%-463.07M | -186.77%-420.91M | -357.37%-410.81M | 227.89%300.38M |
| Add:Begin period cash and cash equivalents | -27.05%593.23M | -32.32%813.19M | -32.32%813.19M | -32.32%813.19M | -32.32%813.19M | 33.33%1.2B | 33.33%1.2B | 33.33%1.2B | 33.33%1.2B | -20.67%901.19M |
| End period cash equivalent | -37.59%177.12M | -27.05%593.23M | -40.56%438.93M | -37.04%491.51M | -64.11%283.79M | -32.32%813.19M | 170.34%738.5M | -43.69%780.66M | -2.54%790.76M | 33.33%1.2B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting